Table 1. Baseline characteristics.
| Treatment (n = 30) | Placebo (n = 29) | P valuea | |
|---|---|---|---|
| Age (years) | 52.40 (±4.64) | 52.28 (±2.24) | 0.90 |
| BMI (kg m-1) | 26.02 (±5.38) | 25.45 (±3.34) | 0.63 |
| FSH (mean, IU/l) | 73.70 (±27.10) | 72.07 (±26.13) | 0.82 |
| Hysterectomy (mean) | 0.10 (±0.30) | 0.10 (±0.30) | 0.97 |
| Smoker (mean) | 0.10 (±0.30) | 0.21 (±0.41) | 0.26 |
| HFF baseline (24hr peak no.) | 18.53 (±7.09) | 15.93 (±7.02) | 0.16 |
| HFI baseline (24hr μS s-1) | 32520 (±20966) | 25590 (±28971) | 0.30 |
| rHFF baseline (24hr peak no.) | 9.5 (±6.44) | 8.55 (±6.87) | 0.59 |
| rHFS baseline (24hr Score) | 17.30 (±12.98) | 17.41 (±16.88) | 0.98 |
Abbreviations: BMI, body mass index; FSH, follicle stimulating hormone; HFF, Hot Flush Frequency; HFI, Hot Flush Intensity; rHFF, self-Reported Hot Flush Frequency; rHFS, self-Reported Hot Flush Severity.
Data are summarised as mean (± SD).
a P values for intergroup differences in baseline parameters determined by unpaired T test.